Free tool

Oncology stocks

We cover 12 companies grouped under the Oncology theme. The median market value in the group is $4.14M. Across the group, the median move over the past trading day is −0.24%. Price change over the past year runs from −96.2% to −57.1% across the middle 80 percent of the group, with a median of −87.9%.

Other lists in this group

Table

12 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
KPTIKaryopharm Therapeutics Inc. Common Stock$42.19MMicro cap−69.57%
IMU.AXImugene Limited$25.70MMicro cap−73.33%
RADXRadiopharm Theranostics Limited$19.55MMicro cap−55.71%
PDSBPDS Biotechnology Corporation$12.40MMicro cap−82.96%
MBRXMoleculin Biotech, Inc.$11.90MMicro cap−95.75%
APVOAptevo Therapeutics Inc.$4.43MMicro cap−92.81%
CRISCuris, Inc.$3.86MMicro cap−3.64%
RNAZTransCode Therapeutics, Inc.$2.68MMicro cap−74.16%
SLXNSilexion Therapeutics Corp$2.04MMicro cap−94.88%
DCOYDecoy Therapeutics Inc.$1.95MMicro cap−95.58%
ATORX.STAlligator Bioscience AB (publ)$1.88MMicro cap−99.30%
BDRXBiodexa Pharmaceuticals Plc$1.07MMicro cap−96.20%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse